NCT07273864

Brief Summary

This study aims to evaluate the effects of auricular press needle therapy, combined with conventional treatment and median nerve electrical stimulation, on promoting arousal and neurological recovery in patients with disorders of consciousness after traumatic brain injury. Sixty patients with a Glasgow Coma Scale (GCS) score of 4-8 were enrolled and randomly assigned in a 1:1 ratio to a control group or an experimental group (30 patients each). Both groups received standard conventional treatment (including surgery when indicated, medications, nutritional support, acupuncture, and complication prevention) combined with median nerve electrical stimulation. The experimental group received auricular press needle therapy (at Heart, Shenmen, Sympathetic, and Subcortex acupoints) on top of the same interventions, and family members were trained to perform daily acupoint massage. The GCS score and Coma Recovery Scale-Revised (CRS-R) score were assessed at baseline, 4 weeks, 6 weeks, and 8 weeks after the start of intervention, and the arousal rate was recorded. The Glasgow Outcome Scale (GOS) was used to evaluate prognosis at 1 month after the end of treatment, and family satisfaction was assessed using a Likert scale at 8 weeks post-intervention. Data were analyzed using SPSS Statistics 27.0, with statistical significance set at p \< 0.05.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 10, 2022

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2023

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 20, 2024

Completed
1.5 years until next milestone

First Submitted

Initial submission to the registry

October 1, 2025

Completed
2 months until next milestone

First Posted

Study publicly available on registry

December 10, 2025

Completed
Last Updated

December 10, 2025

Status Verified

November 1, 2025

Enrollment Period

1.8 years

First QC Date

October 1, 2025

Last Update Submit

December 7, 2025

Conditions

Keywords

Traumatic Brain InjuryMedian Nerve Electrical StimulationDisorders of ConsciousnessPromotion of ArousalEar Acupoint Press-Needl

Outcome Measures

Primary Outcomes (1)

  • Awakening Rate of Patients with Consciousness Disorder After Traumatic Brain Injury (TBI)

    1. Description Primary outcome is awakening rate at 8 weeks post-intervention in TBI patients with consciousness disorder (GCS 4-8). "Awakening" = independent eye-opening ≥30s, or clear responses (limb retraction, simple verbal answers) to verbal/pain stimuli, confirmed by 2 attending physicians. 2. Time Frame 8 weeks after intervention start (end of full course). 3. Assessment Method Record weekly awakening status during 8-week intervention; Count awakened patients in Arm 1 (control) and Arm 2 (experimental) at week 8; Calculate rate: (Awakened patients / Total patients per group) × 100%. 4. Rationale Awakening is core rehabilitation goal for these patients, directly reflecting intervention efficacy in consciousness recovery. More intuitive and clinically meaningful than other indicators (e.g., GCS) for evaluating core therapeutic effect.

    8 weeks after the start of the intervention (which is the end of the full intervention course for the study).

Secondary Outcomes (1)

  • Change in Glasgow Coma Scale (GCS) Score

    Baseline (pre-intervention), 4 weeks, 6 weeks, 8 weeks post-intervention.

Study Arms (2)

Conventional Treatment + Median Nerve Electrical Stimulation + Auricular Press-Needle Therapy

EXPERIMENTAL

Conventional treatment combined with right median nerve electrical stimulation and auricular press-needle therapy.

Other: Conventional Neurosurgical and Supportive CareDevice: Right Median Nerve Electrical StimulationDevice: Auricular Press-Needle Therapy

Conventional Treatment + Median Nerve Electrical Stimulation

ACTIVE COMPARATOR

Conventional treatment combined with right median nerve electrical stimulation.

Other: Conventional Neurosurgical and Supportive CareDevice: Right Median Nerve Electrical Stimulation

Interventions

Routine comprehensive management for severe traumatic brain injury, including surgical intervention when indicated, intracranial pressure monitoring if needed, neuroprotective and symptomatic medications (e.g., anti-epileptic drugs), nutritional support, complication prevention, nursing care, and conventional rehabilitation therapy. All care was provided in accordance with institutional standard protocols.

Conventional Treatment + Median Nerve Electrical StimulationConventional Treatment + Median Nerve Electrical Stimulation + Auricular Press-Needle Therapy

The multifunctional electrical therapy apparatus (Model MT1023; Shenzhen Dongdixin Technology Co., Ltd.) was used. A single skin electrode was placed 2 cm proximal to the right wrist crease on the volar forearm. Stimulation parameters: asymmetric biphasic (direct current) square wave, intensity up to 20 mA, pulse width 300 ms, frequency 40 Hz, intermittent mode (20 seconds on, 40 seconds off). Sessions lasted 60 minutes and were delivered twice daily, 7 days per week, for 8 weeks.

Conventional Treatment + Median Nerve Electrical StimulationConventional Treatment + Median Nerve Electrical Stimulation + Auricular Press-Needle Therapy

Disposable sterile press needles (0.2 mm × 0.5 mm thumbtack type) were inserted bilaterally at the auricular acupoints Shenmen (TF4) and Subcortex/Brain (AT4) \[some records also included Heart (CO15) and Sympathetic\]. Needles were retained for 48 hours, replaced every 2-3 days, and the cycle was repeated for the entire 8-week treatment period. Family members were trained to massage each point three times daily.

Conventional Treatment + Median Nerve Electrical Stimulation + Auricular Press-Needle Therapy

Eligibility Criteria

Age20 Years - 86 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Disorder of consciousness following traumatic brain injury
  • Stable vital signs with no evidence of active bleeding
  • Glasgow Coma Scale (GCS) score between 4 and 8 (inclusive)
  • No severe vital organ dysfunction and normal cardiac function
  • Time from injury to enrollment ≤ 10 days
  • No prior history of traumatic brain injury, epilepsy, or pregnancy

You may not qualify if:

  • Presence of other critical illnesses (e.g., severe cardiovascular, hepatic, or renal disease)
  • Known allergy to the electrodes or adhesive patches used in electrical stimulation
  • Lack of cooperation or refusal by the patient's legal guardian/family members

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The First Affiliated Hospital of Gannan Medical University

Jiangxi, Ganzhou, 341000, China

Location

MeSH Terms

Conditions

Brain Injuries, TraumaticCerebral HemorrhageConsciousness Disorders

Interventions

Palliative Care

Condition Hierarchy (Ancestors)

Brain InjuriesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesCraniocerebral TraumaTrauma, Nervous SystemWounds and InjuriesIntracranial HemorrhagesCerebrovascular DisordersVascular DiseasesCardiovascular DiseasesHemorrhagePathologic ProcessesPathological Conditions, Signs and SymptomsNeurobehavioral ManifestationsNeurologic ManifestationsSigns and SymptomsNeurocognitive DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Patient CareTherapeuticsHealth ServicesHealth Care Facilities Workforce and Services

Study Officials

  • Hai N Li, Middle Initia

    First Affiliated Hospital of Gannan Medical University

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Chief Therapist, Department of Rehabilitation

Study Record Dates

First Submitted

October 1, 2025

First Posted

December 10, 2025

Study Start

February 10, 2022

Primary Completion

November 30, 2023

Study Completion

March 20, 2024

Last Updated

December 10, 2025

Record last verified: 2025-11

Data Sharing

IPD Sharing
Will not share

Patient Privacy Protection: Collected IPD includes sensitive personal health information. Per China's Personal Information Protection Law and hospital ethical requirements, sharing IPD risks unauthorized disclosure, violating patients' information security rights. Informed Consent Limitations : Participants' signed consent only authorizes IPD use for this study's research goals, not sharing with external parties. Without additional ethical approval and patient re-consent, sharing is non-compliant with ethical commitments. Data Security \& Integrity : IPD is managed under The First Affiliated Hospital of Gannan Medical University's security system. External sharing may cause data tampering, improper use, or loss, compromising result integrity and analysis credibility. Future IPD sharing (e.g., collaborative research) will require hospital Ethics Committee approval, patient re-consent, and strict de-identification/transfer protocols to meet legal and ethical standards.

Locations